• 22 Oct 2025

Dr Sam Oliver

Sam obtained his undergraduate degree in Chemistry from the University of Liverpool in 2008. He then joined Prof. P. Andrew Evans’ research group to work on the development of novel rhodium-catalysed allylic substitution reactions, earning his PhD in 2012. On moving into industry with Albany Molecular Research Inc. (AMRI) in 2013, Sam spent two years in process R&D supporting large scale API manufacturing before embarking on a four-year stint working at the interface of discovery and process chemistry as part of a collaboration with Eli Lilly & Co. During this time, Sam was involved in a range of programmes comprising route scouting, custom synthesis and the development & optimisation of scalable routes to pre-clinical drug candidates. Nearly two years after assuming a team leadership role within AMRI, Sam joined CatSci Ltd in October 2019. In his current position as a Group Leader, Sam is committed to ensuring the timely delivery of perfect-for-purpose chemistry solutions to CatSci’s customers across the globe.

Resources & Insights

  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News
  • 11 May 2026
CatSci Achieves ISO 27001 Certification, Demonstrating its Commitment to Client Data Security
  • News
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB
  • 23 Mar 2026
HTE-Enabled Suzuki Optimisation for Cost Reduction
  • High Throughput Experimentation
  • HTE
  • Case Studies
244 KB